PDB44 COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.926
https://www.valueinhealthjournal.com/article/S1098-3015(19)33304-2/fulltext
Title : PDB44 COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT VERSUS LASER PHOTOCOAGULATION AND RANIBIZUMAB IN THE TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA IN CHINA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33304-2&doi=10.1016/j.jval.2019.09.926
First page :
Section Title :
Open access? : No
Section Order : 10817
Categories :
Tags :
Regions :
ViH Article Tags :